What should you know about intraperitoneal chemotherapy for ovarian cancer?

Short answer
Intraperitoneal chemotherapy delivers cancer medicine into the abdominal cavity, allowing treatment to reach the lining and nearby tissues directly.
This answers one question. It is not a diagnosis and does not replace an assessment by a licensed doctor.
At a glance
- Treatment route
- Into the abdominal cavity through a catheter or implanted port
- Treatment setting
- Planned by the oncology team and may involve monitored clinic care
- Main monitoring
- Symptoms, port or wound changes, blood counts, kidney function, and hydration
What intraperitoneal chemotherapy means
The peritoneum is the thin lining inside the abdomen. With intraperitoneal treatment, medicine is placed into this space through a catheter or implanted port, rather than being given only through a vein. The medicine can circulate around organs and areas where ovarian cancer cells may be present. Treatment may be used after surgery, alongside intravenous chemotherapy, or in another sequence chosen by the oncology team. It is not suitable for every person: the decision depends on the cancer's location and extent, previous treatment, recovery from surgery, kidney function, blood counts, and overall health.
An abdominal port can remain in place for repeated treatments. A session may involve fluid entering the abdomen, a period for the medicine to work, and drainage or removal of the fluid according to the treatment plan. Common practical concerns include abdominal pressure, nausea, pain, fatigue, and changes in blood counts. Your team can prescribe medicines for nausea and explain how to protect the port and incision sites.
How to prepare and take part
Before treatment, ask how the port will be placed, whether you need blood tests or scans, which medicines and supplements to pause, and how eating and drinking should be managed on treatment days. Keep a written list of symptoms, temperature readings if advised, and medicines. Arrange help with transport and daily tasks if fatigue or abdominal discomfort is expected. Do not remove, press, or clean a port dressing unless your clinical team has given you instructions.
The wider plan may include ovarian cancer debulking surgery, intravenous chemotherapy, or supportive care. Your clinician may also discuss pelvic ultrasound, genomic tumour profiling, or BRCA genetic testing when these are relevant to diagnosis, treatment selection, or family risk.
When to seek care
Contact your oncology service promptly if you develop a fever, chills, worsening abdominal pain or swelling, repeated vomiting, severe diarrhoea, inability to keep fluids down, new shortness of breath, or marked weakness. Seek urgent help for confusion, fainting, severe breathing difficulty, or uncontrolled bleeding. Redness, warmth, pus, or increasing tenderness around the port or wound can indicate infection and should be reported without waiting for the next appointment.
Questions for your doctor
Ask why intraperitoneal treatment is being recommended for you, how it fits with chemotherapy through a vein or surgery, how the port will be monitored, which side effects require a same-day call, and what happens if a treatment must be delayed. Ask who to contact outside clinic hours and whether palliative care or another supportive service could help with pain, nausea, sleep, nutrition, or emotional strain.
Questions people ask
Is intraperitoneal chemotherapy the same as intravenous chemotherapy?
No. Intraperitoneal chemotherapy is placed into the abdominal cavity, while intravenous chemotherapy enters the bloodstream through a vein. Some treatment plans use both routes.
Will I need a port for intraperitoneal treatment?
Often, repeated treatment uses an implanted abdominal port or another catheter. Your surgeon and oncology team will explain the device, wound care, and when it should be reported.
What should I do if I feel unwell after treatment?
Use the contact instructions from your oncology service and report fever, worsening abdominal symptoms, repeated vomiting, breathing difficulty, or port-site changes promptly. Severe breathing difficulty, fainting, confusion, or uncontrolled bleeding needs urgent help.
Related
Related reading
Keep reading
Cancer care in the UAE
Hospitals & Medical Centers in Abu Dhabi
Most UAE cancer care is delivered inside hospital services rather than by standalone oncology clinics, so these are licensed hospitals & medical centers listed in Abu Dhabi. Confirm the specific cancer service exists before you travel, and know that asking for a second opinion is routine.
Ahalia Hospital Musaffah Building - Musaffah - Musaffah Industrial - Abu Dhabi - United Arab Emirates
Accepts: Daman, Thiqa, AXA, Cigna +26 more
Al Ruwais Industrial City - Abu Dhabi - United Arab Emirates
Accepts: Daman, Thiqa, AXA, Cigna +30 more
Abu Dhabi, Abu Dhabi
Accepts: Daman, Thiqa, AXA, Cigna +30 more
Second opinions are routine in cancer care and asking for one does not affect your treatment. How to arrange a second opinion in the UAE.
Ordered by verification status and how complete each clinic's public record is, then alphabetically. This is a directory listing, not a ranking — Zavis does not rate or recommend providers.
A factual listing drawn from the DHA, DOH and MOHAP licence registers. It is not a referral, an endorsement, or advice that any of these providers is right for you.
Medical disclaimer. This page is general health information, not medical advice, and it cannot diagnose you. Always consult a licensed healthcare provider about your own symptoms and treatment. In an emergency in the UAE, call 998 for an ambulance.